Search

everythinglearnresearchcommunity

for

Search:↓

Ruxolitinib helps regrow hair in alopecia areata by blocking inflammation, reducing stress, and controlling cell death.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Certain astrocytes can protect the brain and improve recovery after a stroke, and a hair loss drug might reduce cancer spread.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.

Finasteride doesn't affect omeprazole metabolism in Japanese people.

Different STUB1 gene mutations cause varied symptoms in autosomal recessive ataxias.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

PRS injections can improve knee function and reduce pain for up to a year.

Finasteride for hair loss in young men may significantly increase the risk of sexual dysfunction.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Oral minoxidil improved hair loss more than oral dutasteride.

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

Dutasteride effectively increases hair density in women with hair loss.

Valproic acid can cause hair color change in older men.

Ruxolitinib treatment may cause eyelash growth.

The FDA rejected a testosterone drug again due to safety concerns.

A compound named ZCZ90 can increase muscle spindle firing, potentially helping treat muscle spasms and hypertension.

Progesterone protects rat brain cells by enhancing GABA A receptor activity.

Finasteride may reduce heart damage in rats.

Botulinum toxin A does not significantly improve hair density or thickness in androgenetic alopecia.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

The treatment cleared psoriasis in some patients but caused side effects in most.

Progesterone can reduce seizures without relying on the GABAA receptor pathway.

Topical Stemoxydine improves hair density in androgenetic alopecia with few side effects.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.